Hazlett, Burt & Watson’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.37M Sell
2,033
-15
-0.7% -$8.91K 0.35% 72
2026
Q2
$1.04M Sell
2,048
-4
-0.2% -$1.92K 0.28% 96
2026
Q1
$1M Buy
2,052
+88
+4% +$47.8K 0.31% 80
2025
Q4
$1.14M Buy
1,964
+244
+14% +$138K 0.36% 64
2025
Q3
$836K Sell
1,720
-40
-2% -$18.6K 0.3% 77
2025
Q2
$714K Buy
1,760
+233
+15% +$97.4K 0.29% 80
2025
Q1
$756K Buy
1,527
+47
+3% +$25.5K 0.34% 68
2024
Q4
$771K Buy
1,480
+101
+7% +$55.5K 0.34% 69
2024
Q3
$854K Buy
1,379
+75
+6% +$44.4K 0.39% 58
2024
Q2
$721K Buy
1,304
+106
+9% +$60.7K 0.37% 61
2024
Q1
$698K Sell
1,198
-55
-4% -$30.9K 0.42% 49
2023
Q4
$668K Sell
1,253
-56
-4% -$27.1K 0.45% 47
2023
Q3
$668K Sell
1,309
-306
-19% -$163K 0.5% 39
2023
Q2
$845K Sell
1,615
-97
-6% -$52.3K 0.63% 23
2023
Q1
$988K Buy
1,712
+55
+3% +$31K 0.81% 22
2022
Q4
$917K Sell
1,657
-2
-0.1% -$1.06K 0.81% 24
2022
Q3
$845K Hold
1,659
– – 0.82% 21
2022
Q2
$902K Buy
1,659
+30
+2% +$16.5K 0.83% 22
2022
Q1
$960K Buy
+1,629
New +$936K 0.76% 25

Other funds holding TMO

Hazlett, Burt & Watson's TMO Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its Thermo Fisher Scientific (TMO) stake by 0.73% in Q3 2026, selling an estimated $8.91K and leaving 2,033 shares worth $1.37M. The position accounts for 0.35% of the portfolio, ranked #72.

Hazlett, Burt & Watson first reported a position in TMO in Q1 2022 and has held it in 19 quarters since. 2,799 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Hazlett, Burt & Watson held 2,033 shares of Thermo Fisher Scientific worth $1.37M as of Q3 2026.
  • Hazlett, Burt & Watson sold 15 Thermo Fisher Scientific shares in Q3 2026, an estimated $8.91K.
  • Thermo Fisher Scientific made up 0.35% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #72 holding.
  • Hazlett, Burt & Watson first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 19 quarters since.
  • 2,799 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.